logo
ProjectForthcoming

ReACT (Resilience Acute Challenge Test): Functional assessment of human adaptive capacity through controlled ex vivo challenge

One of 10,000+ projects Taiyo tracks in Italy.

Source: EU Funding & Tenders Portal

Modern medicine offers a wide range of diagnostic tools to detect disease and estimate risk, yet it lacks a standardized method to measure an individual’s adaptive reserve, i.e. a systemic biological capacity that determines how the organism maintains stability when challenged. This adaptive reserve reflects the dynamic regulatory potential of the system, rather than the presence or absence of pat

Status
Prospective
Sector
Hydrogen, Hospital
Location
Italy
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about ReACT (Resilience Acute Challenge Test): Functional assessment of human adaptive capacity through controlled ex vivo challenge

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “ReACT (Resilience Acute Challenge Test): Functional assessment of human adaptive capacity through controlled ex vivo challenge” is an infrastructure initiative in the Hydrogen sector, located in Italy. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Modern medicine offers a wide range of diagnostic tools to detect disease and estimate risk, yet it lacks a standardized method to measure an individual’s adaptive reserve, i.e. a systemic biological capacity that determines how the organism maintains stability when challenged. This adaptive reserve reflects the dynamic regulatory potential of the system, rather than the presence or absence of pathology. Despite its central role in health trajectories, it remains indirectly inferred rather than directly quantified. ReACT (Resilience Acute Challenge Test) is a functional ex vivo assay designed to quantify this intrinsic adaptive capacity. Using peripheral EDTA whole blood, aliquots are exposed for a defined period to graded concentrations of hydrogen peroxide (H2O2), generating a controlled oxidative challenge. LINE-1 methylation is quantified across doses and modelled as an individualized dose–response curve. From this parametric response, a Functional Adaptive Capacity Index is derived, capturing proportionality, stability, and deviation from calibrated reference geometry. The oxidative challenge serves as a calibrated biological probe to reveal intrinsic adaptive reserve. ReACT will be validated in two structured validation models, cyclic therapeutic regimens and physiological load cycles, selected for their reproducible challenge–recovery dynamics and measurable short-term endpoints. These models enable rigorous assessment of assay robustness, reproducibility, and functional coherence within the PoC timeframe. The project will deliver a standardized ex vivo protocol, reproducibility metrics, predefined performance thresholds, and a validated computational framework for index derivation, together with an intellectual property and preliminary regulatory positioning strategy. By converting adaptive reserve into a reproducible biological readout, ReACT advances the translational integration of adaptive capacity into defined decision-support contexts.

Location

Country

Italy

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Hydrogen, Hospital

Article published date

2026-09-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project